1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits for the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. Analyst View
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. ALPHA-1 ANTITRYPSIN DEFICIENCY TREATMENT MARKET BY TREATMENT TYPE
5.1. Introduction
5.2. Augmentation Therapy
5.2.1. Market Trends and Opportunities
5.2.2. Growth Prospects
5.2.3. Aralast
5.2.4. Prolastin
5.2.5. Raspreeza
5.2.6. Glassia
5.3. Bronchodilator
5.3.1. Market Trends and Opportunities
5.3.2. Growth Prospects
5.4. Corticosteroids
5.4.1. Market Trends and Opportunities
5.4.2. Growth Prospects
5.5. Oxygen Therapy
5.5.1. Market Trends and Opportunities
5.5.2. Growth Prospects
5.6. Others
5.6.1. Market Trends and Opportunities
5.6.2. Growth Prospects
6. ALPHA-1 ANTITRYPSIN DEFICIENCY TREATMENT MARKET BY ROUTE OF ADMINISTRATION
6.1. Introduction
6.2. Parenteral
6.2.1. Market Trends and Opportunities
6.2.2. Growth Prospects
6.3. Inhalations
6.3.1. Market Trends and Opportunities
6.3.2. Growth Prospects
6.4. Oral
6.4.1. Market Trends and Opportunities
6.4.2. Growth Prospects
7. ALPHA-1 ANTITRYPSIN DEFICIENCY TREATMENT MARKET BY END-USER
7.1. Introduction
7.2. Speciality Clinics
7.2.1. Market Trends and Opportunities
7.2.2. Growth Prospects
7.3. Hospitals
7.3.1. Market Trends and Opportunities
7.3.2. Growth Prospects
7.4. Pharmacies
7.4.1. Market Trends and Opportunities
7.4.2. Growth Prospects
7.5. Others
7.5.1. Market Trends and Opportunities
7.5.2. Growth Prospects
8. ALPHA-1 ANTITRYPSIN DEFICIENCY TREATMENT MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Treatment Type
8.2.2. By Route of Administration
8.2.3. By End-User
8.2.4. By Country
8.2.4.1. United States
8.2.4.1.1. Market Trends and Opportunities
8.2.4.1.2. Growth Prospects
8.2.4.2. Canada
8.2.4.2.1. Market Trends and Opportunities
8.2.4.2.2. Growth Prospects
8.2.4.3. Mexico
8.2.4.3.1. Market Trends and Opportunities
8.2.4.3.2. Growth Prospects
8.3. South America
8.3.1. By Treatment Type
8.3.2. By Route of Administration
8.3.3. By End-User
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.1.1. Market Trends and Opportunities
8.3.4.1.2. Growth Prospects
8.3.4.2. Argentina
8.3.4.2.1. Market Trends and Opportunities
8.3.4.2.2. Growth Prospects
8.3.4.3. Others
8.3.4.3.1. Market Trends and Opportunities
8.3.4.3.2. Growth Prospects
8.4. Europe
8.4.1. By Treatment Type
8.4.2. By Route of Administration
8.4.3. By End-User
8.4.4. By Country
8.4.4.1. United Kingdom
8.4.4.1.1. Market Trends and Opportunities
8.4.4.1.2. Growth Prospects
8.4.4.2. Germany
8.4.4.2.1. Market Trends and Opportunities
8.4.4.2.2. Growth Prospects
8.4.4.3. France
8.4.4.3.1. Market Trends and Opportunities
8.4.4.3.2. Growth Prospects
8.4.4.4. Italy
8.4.4.4.1. Market Trends and Opportunities
8.4.4.4.2. Growth Prospects
8.4.4.5. Spain
8.4.4.5.1. Market Trends and Opportunities
8.4.4.5.2. Growth Prospects
8.4.4.6. Others
8.4.4.6.1. Market Trends and Opportunities
8.4.4.6.2. Growth Prospects
8.5. Middle East and Africa
8.5.1. By Treatment Type
8.5.2. By Route of Administration
8.5.3. By End-User
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.1.1. Market Trends and Opportunities
8.5.4.1.2. Growth Prospects
8.5.4.2. UAE
8.5.4.2.1. Market Trends and Opportunities
8.5.4.2.2. Growth Prospects
8.5.4.3. Others
8.5.4.3.1. Market Trends and Opportunities
8.5.4.3.2. Growth Prospects
8.6. Asia Pacific
8.6.1. By Treatment Type
8.6.2. By Route of Administration
8.6.3. By End-User
8.6.4. By Country
8.6.4.1. Japan
8.6.4.1.1. Market Trends and Opportunities
8.6.4.1.2. Growth Prospects
8.6.4.2. China
8.6.4.2.1. Market Trends and Opportunities
8.6.4.2.2. Growth Prospects
8.6.4.3. India
8.6.4.3.1. Market Trends and Opportunities
8.6.4.3.2. Growth Prospects
8.6.4.4. South Korea
8.6.4.4.1. Market Trends and Opportunities
8.6.4.4.2. Growth Prospects
8.6.4.5. Taiwan
8.6.4.5.1. Market Trends and Opportunities
8.6.4.5.2. Growth Prospects
8.6.4.6. Thailand
8.6.4.6.1. Market Trends and Opportunities
8.6.4.6.2. Growth Prospects
8.6.4.7. Indonesia
8.6.4.7.1. Market Trends and Opportunities
8.6.4.7.2. Growth Prospects
8.6.4.8. Others
8.6.4.8.1. Market Trends and Opportunities
8.6.4.8.2. Growth Prospects
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Takeda Pharmaceutical Company Ltd.
10.2. Kamada Pharmaceuticals
10.3. Pfizer Inc.
10.4. Grifols
10.5. GlaxoSmithKline
10.6. CSL Behring
10.7. LFB Biomedicaments S.A.